STereotactic Arrhythmia Radioablation (STAR): the Standardized Treatment and Outcome Platform for Stereotactic Therapy Of Re-entrant tachycardia by a Multidisciplinary consortium (STOPSTORM.eu) and review of current patterns of STAR practice in Europe
Jazyk angličtina Země Velká Británie, Anglie Médium print
Typ dokumentu přehledy, časopisecké články
PubMed
36879464
PubMed Central
PMC10105846
DOI
10.1093/europace/euac238
PII: 7069964
Knihovny.cz E-zdroje
- Klíčová slova
- Cardiac arrhythmias, Consortium, EU Horizon 2020, Stereotactic arrhythmia radioablation, Stereotactic body radiotherapy, Ventricular tachycardia,
- MeSH
- katetrizační ablace * škodlivé účinky metody MeSH
- komorová tachykardie * MeSH
- lidé MeSH
- prospektivní studie MeSH
- srdeční arytmie MeSH
- srdeční komory MeSH
- výsledek terapie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
The EU Horizon 2020 Framework-funded Standardized Treatment and Outcome Platform for Stereotactic Therapy Of Re-entrant tachycardia by a Multidisciplinary (STOPSTORM) consortium has been established as a large research network for investigating STereotactic Arrhythmia Radioablation (STAR) for ventricular tachycardia (VT). The aim is to provide a pooled treatment database to evaluate patterns of practice and outcomes of STAR and finally to harmonize STAR within Europe. The consortium comprises 31 clinical and research institutions. The project is divided into nine work packages (WPs): (i) observational cohort; (ii) standardization and harmonization of target delineation; (iii) harmonized prospective cohort; (iv) quality assurance (QA); (v) analysis and evaluation; (vi, ix) ethics and regulations; and (vii, viii) project coordination and dissemination. To provide a review of current clinical STAR practice in Europe, a comprehensive questionnaire was performed at project start. The STOPSTORM Institutions' experience in VT catheter ablation (83% ≥ 20 ann.) and stereotactic body radiotherapy (59% > 200 ann.) was adequate, and 84 STAR treatments were performed until project launch, while 8/22 centres already recruited VT patients in national clinical trials. The majority currently base their target definition on mapping during VT (96%) and/or pace mapping (75%), reduced voltage areas (63%), or late ventricular potentials (75%) during sinus rhythm. The majority currently apply a single-fraction dose of 25 Gy while planning techniques and dose prescription methods vary greatly. The current clinical STAR practice in the STOPSTORM consortium highlights potential areas of optimization and harmonization for substrate mapping, target delineation, motion management, dosimetry, and QA, which will be addressed in the various WPs.
Bioethics Unit Azienda Unità Sanitaria Locale IRCCS Via Amendola 2 Reggio Emilia 42100 Italy
Cardiology Arrhythmology Center AUSL IRCCS di Reggio Emilia Via Amendola 2 Reggio Emilia 42100 Italy
Department of Cardiology Catharina Hospital Michelangelolaan 2 Eindhoven 5623 EJ The Netherlands
Department of Medical Sciences University of Turin Via Verdi 8 Torino 10124 Italy
Department of Oncology University of Torino Via Giuseppe Verdi 8 Torino 10124 Italy
Department of Radiation Oncology Hospital General Valencia Av Tres Cruces 2 Valencia 46014 Spain
Department of Radio Oncology Lausanne University Hospital Rue du Bugnon 21 Lausanne 1011 Switzerland
Department of Rhythmology Charité University Medicine Berlin Charitéplatz 1 10117 Berlin Germany
National Center of Oncological Hadrontherapy Strada Campeggi 53 Pavia PV27100 Italy
Zobrazit více v PubMed
Movsisyan NK, Vinciguerra M, Medina-Inojosa JR, Lopez-Jimenez F. Cardiovascular diseases in central and Eastern Europe: a call for more surveillance and evidence-based health promotion. Ann Glob Health 2020;86;1–10. PubMed PMC
Cronin EM, Bogun FM, Maury P, Peichl P, Chen M, Namboodiri Net al. . HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias. Heart Rhythm 2019: 21(8); 1143–4. PubMed
Tung R, Vaseghi M, Frankel DS, Vergara P, Di Biase L, Nagashima Ket al. . Freedom from recurrent ventricular tachycardia after catheter ablation is associated with improved survival in patients with structural heart disease: an international VT ablation center collaborative group study. Heart Rhythm 2015;12:1997–2007. PubMed PMC
Fernandez-Armenta J, Soto-Iglesias D, Silva E, Penela D, Jáuregui B, Linhart Met al. . Safety and outcomes of ventricula tachycardia substrate ablation during Sinus rhythm: a prospective multicenter registry. JACC Clin Electrophysiol 2020;6:1435–48. PubMed
Jumeau R, Ozsahin M, Schwitter J, Elicin O, Reichlin T, Roten Let al. . Stereotactic radiotherapy for the management of refractory ventricular tachycardia: promise and future directions. Front Cardiovasc Med 2020;7:108. PubMed PMC
Whitaker J, Mak RH, Zei PC. Non-invasive ablation of arrhythmias with stereotactic ablative radiotherapy. Trends Cardiovasc Med 2022:32(5):287–296. PubMed
Sharma A, Wong D, Weidlich G, Fogarty T, Jack A, Sumanaweera Tet al. . Noninvasive stereotactic radiosurgery (CyberHeart) for creation of ablation lesions in the atrium. Heart Rhythm 2010;7:802–10. PubMed
Loo BW Jr, Soltys SG, Wang L, Lo A, Fahimian BP, Lagaru Aet al. . Stereotactic ablative radiotherapy for the treatment of refractory cardiac ventricular arrhythmia. Circ Arrhythm Electrophysiol 2015;8:748–50. PubMed
Cvek J, Neuwirth R, Knybel L, Molenda L, Otahal B, Pindor Jet al. . Cardiac radiosurgery for malignant ventricular tachycardia. Cureus 2014;6:e190.
Miszczyk M, Jadczyk T, Golba K, Wojakowski W, Wita K, Bednarek Jet al. . Clinical evidence behind stereotactic radiotherapy for the treatment of ventricular tachycardia (STAR)—A comprehensive review. J Clin Med 2021;10:1238. PubMed PMC
Abdel-Kafi S, Sramko M, Omara S, de Riva M, Cvek J, Peichl Pet al. . Accuracy of electroanatomical mapping-guided cardiac radiotherapy for ventricular tachycardia: pitfalls and solutions. Europace 2021:23(12):1989–1997. PubMed
Boda-Heggemann J, Blanck O, Mehrhof F, Ernst F, Buergy D, Fleckenstein Jet al. . Interdisciplinary clinical target volume generation for cardiac radioablation: multicenter benchmarking for the RAdiosurgery for VENtricular TAchycardia (RAVENTA) trial. Int J Radiation Oncol Biol Phys 2021;110:745–56. PubMed
Lydiard S, Blanck O, Hugo G, O’Brien R, Keall P. A review of cardiac radioablation (CR) for arrhythmias: procedures. Technology, and future opportunities. Int J Radiation Oncol Biol Phys 2020;109:783–800. PubMed
Zhang DM, Navara R, Yin T, Szymanski J, Goldsztejn U, Kenkel Cet al. . Cardiac radiotherapy induces electrical conduction reprogramming in the absence of transmural fibrosis. Nat Commun 2021;12:5558. PubMed PMC
Kim JS, Choi SW, Park Y, Kim SJ, Choi CH, Cha Met al. . Impact of high-dose irradiation on human iPSC-derived cardiomyocytes using multi-electrode arrays: implications for the antiarrhythmic effects of cardiac radioablation. Int J Mol Sci 2021;23:351. PubMed PMC
Kautzner J, Jedlickova K, Sramko M, Peichl P, Cvek J, Knybel Let al. . Radiation-induced changes in ventricular myocardium after stereotactic body radiotherapy for recurrent ventricula tachycardia. JACC Clin Electrophysiol 2021;7:1487–92. PubMed
Blanck O, Boda-Heggemann J, Hohmann S, Mehrhof F, Krug D. [Cardiac stereotactic radiotherapy induces electrical conduction reprogramming]. Strahlenther Onkol 2022;198:209–11. PubMed PMC
Cuculich PS, Schill MR, Kashani R, Mutic S, Lang A, Cooper Det al. . Noninvasive cardiac radiation for ablation of ventricular tachycardia. N Engl J Med 2017;377:2325–36. PubMed PMC
Kovacs B, Mayinger M, Schindler M, Steffel J, Andratschke N, Saguner AM. Stereotactic radioablation of ventricular aahythmias in patients with strucutral heart disease—A systematic review. Radiother Oncol 2021;162:132–9. PubMed
Robinson CG, Samson PP, Moore KMS, Hugo GD, Knutson N, Mutic Set al. . Phase I/II trial of electrophysiology-guided noninvasive cardiac radioablation for ventricular tachycardia. Circulation 2019;139:313–21. PubMed PMC
van der Ree MH, Blanck O, Limpens J, Lee CH, Balgobind BV, Dieleman EMTet al. . Cardiac radioablation—A systematic review. Heart Rhythm 2020;17:1381–92. PubMed
Krug D, Blanck O, Demming T, Dottermusch M, Koch K, Hirt Met al. . Stereotactic body radiotherapy for ventricular tachycardia (cardiac radiosurgery). Strahlenther Onkol 2020;196:23–30. PubMed
Blanck O, Buergy D, Vens M, Eidinger L, Zaman A, Krug Det al. . Radiosurgery for ventricular tachycardia: preclinical and clinical evidence and study design for a German multi-center multi-platform feasibility trial (RAVENTA). Clin Res Cardiol 2019;109:1319–32. PubMed PMC
Miszczyk M, Jadczyk T, Tomasik B, Latusek T, Bednarke J, Kurzelowski Ret al. . Stereotactic management of arrhythmia—radiosurgery in treatment of ventricular tachycardia (SMART-VT)—clinical trial protocol and study rationale. OncoReview 2020;10:123–9.
Carbucicchio C, Jereczek-Fossa BA, Andreini D, Catto V, Piperno G, Conte Eet al. . STRA-MI-VT (STereotactic RadioAblation by multimodal imaging for ventricular tachycardia): rationale and design of an Italian experimental prospective study. J Interv Card Electrophysiol 2020;61:585–93. PubMed PMC
Guckenberger M, Baus WW, Blanck O, Combs SE, Debus J, Engenhart-Cabillic Ret al. . Definition and quality requirements for stereotactic radiotherapy: consensus statement from the DEGRO/DGMP working group stereotactic radiotherapy and radiosurgery. Strahlenther Onkol 2020;196:417–20. PubMed PMC
IAEA . Dosimetry of Small Static Fields Used in External Beam Radiotherapy, An International Code of Practice for Reference and Relative Dose Determination. Technical Reports Series 2017 No. 483. ISBN: 978-92-0-105916-1. https://www-pub.iaea.org/MTCD/Publications/PDF/D483_web.pdf.
Brownstein J, Afzal M, Okabe T, Harfi T, Tong MS, Thomas Eet al. . Method and atlas to enable targeting for cardiac radioablation employing the American heart association segmented model. Int J Radiat Oncol Biol Phys 2021;111:178–85. PubMed
van der Ree MH, Visser J, Planken N, Dieleman EMT, Boekholdt SM, Balgobind BVet al. . Standardizing the cardiac radioablation targeting workflow: enabling semi-automated angulation and segmentation of the heart according to the American heart association segmented model. Adv Radiat Oncol 2022;7(4):100928. PubMed PMC
Hohmann S, Henkenberens C, Zormpas C, Christiansen H, Bauersachs J, Duncker Det al. . A novel open-source software-based high-precision workflow for target definition in cardiac radioablation. J Cardiovasc Electrophysiol 2020;31:2689–95. PubMed
Brett CL, Cook JA, Aboud AA, Karim R, Shinohara ET, Stevenson WG. Novel workflow for conversion of catheter-based electroanatomic mapping to DICOM imaging for noninvasive radioablation of ventricular tachycardia. Pract Radiat Oncol 2021;11:84–8. PubMed
Lee J, Bates M, Shepherd E, Riley S, Henshaw M, Metherall Pet al. . Cardiac stereotactic ablative radiotherapy for control of refractory ventricular tachycardia: initial UK multicentre experience. Open Heart 2021;8:e001770. PubMed PMC
Duane F, Aznar MC, Bartlett F, Cutter DJ, Darby SC, Jagsi Ret al. . A cardiac contouring atlas for radiotherapy. Radiother Oncol 2017;122:416–22. PubMed PMC
Milo MLH, Offersen BV, Bechmann T, Diederichsen ACP, Hansen CR, Holtved Eet al. . Delineation of whole heart and substructures in thoracic radiation therapy: national guidelines and contouring atlas by the danish multidisciplinary cancer groups. Radiother Oncol 2020;150:121–7. PubMed
Feng M, Moran JM, Koelling T, Chughtai A, Chan JL, Freedman Let al. . Development and validation of a heart atlas to study cardiac exposure to radiation following treatment for breast cancer. Int J Radiat Oncol Biol Phys 2011;79:10–8. PubMed PMC
Loap P, Servois V, Dhonneur G, Kirov K, Fourquet A, Kirova Y. A radiation therapy contouring atlas for cardiac conduction node delineation. Pract Radiat Oncol 2021;11:e434–7. PubMed
Krug D, Blanck O, Andratschke N, Guckenberger M, Jumeau R, Mehrhof Fet al. . Recommendations regarding cardiac stereotactic body radiotherapy for treatment refractory ventricular tachycardia. Heart Rhythm 2021;18:2137–45. PubMed
Scholz EP, Seidensaal K, Naumann P, André F, Katus HA, Debus J. Risen from the dead: cardiac stereotactic ablative radiotherapy as last rescue in a patient with refractory ventricular fibrillation storm. HeartRhythm Case Rep 2019;5:329–32. PubMed PMC
Jumeau R, Ozsahin M, Schwitter J, Vallet V, Duclos F, Zeverino Met al. . Rescue procedure for an electrical storm using robotic non-invasive cardiac radio-ablation. Radiother Oncol 2018;128:189–91. PubMed
Kuo L, Liang JJ, Nazarian S, Marchlinski FE. Multimodality imaging to guide ventricular tachycardia ablation in patients with non-ischaemic cardiomyopathy. Arrhythm Electrophysiol Rev 2019;8:255–64. PubMed PMC
Duell J, Dilsizian V, Smith M, Chen W, Dickfeld T. Nuclear imaging guidance for ablation of ventricular arrhythmias. Curr Caridiol Rep 2016;18:19. PubMed
Qian PC, Quadros K, Aguilar M, Wie C, Boeck M, Bredfeldt Jet al. . Substrate modification using stereotactic radioablation to treat refractory ventricular tachycardia in patients with ischemic cardiomyopathy. JACC Clin Electrophysiol 2022;8:49–58. PubMed
Zhao M, Vaartjes I, Klipstein-Grobusch K, Kotseva K, Jennings C, Grobbee DEet al. . Quality assurance and the need to evaluate interventions and audit programme outcomes. Eur J Prev Cardiol 2017;24:123–8. PubMed
Priori SG, Blomström-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm Jet al. . ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart 2015;36:2793–867. PubMed
Sawhney V, Volkova E, Shaukat M, Khan F, Segal O, Ahsan Set al. . Impact of attributed audit on procedural performance in cardiac electrophysiology catheter laboratory. J Interv Card Electrophysiol 2019;56:199–203. PubMed
Bhattacharyya S, James R, Rimington H, Allen J, Lee L, Fox Ket al. . Development of a national echocardiography quality improvement programme: insights into feasibility, uptake, and clinical utility. Eur Heart 2014;15:747–52. PubMed
Brock KK, Mutic S, McNutt TR, Li H, Kessler ML. Use of image registration and fusion algorithms and techniques in radiotherapy: report of the AAPM radiation therapy committee task group No. 132. Med Phys 2017;44:e43–76. PubMed
Schmitt D, Blanck O, Gauer T, Fix MK, Brunner TB, Fleckenstein Jet al. . Technological quality requirements for stereotactic radiotherapy: expert review group consensus from the DGMP working group for physics and technology in stereotactic radiotherapy. Strahlenther Onkol 2020;196:421–43. PubMed PMC
Mir R, Kelly SM, Xiao Y, Moore A, Clark CH, Clementel Eet al. . Organ at risk delineation for radiation therapy clinical trials: global harmonization group consensus guidelines. Radiother Oncol 2020;150:30–9. PubMed
Timmerman R. A story of hypofractionation and the table on the wall. Int J Radiat Oncol Biol Phys 2022;112:4–21. PubMed
Knutson NC, Samson PP, Hugo GD, Goddu SM, Reynoso FJ, Kavanaugh JAet al. . Radiation therapy workflow and dosimetric analysis from a phase 1/2 trial of noninvasive cardiac radioablation for ventricular tachycardia. Int J Radiat Oncol Biol Phys 2019;104:1114–23. PubMed
Gauer T, Sothmann T, Blanck O, Petersen C, Werner R. Under-reported dosimetry errors due to interplay effects during VMAT dose delivery in extreme hypofractionated stereotactic radiotherapy. Strahlenther Onkol 2018;194:570–9. PubMed
Seuntjens J, Lartigau EF, Cora S, Ding GX, Goetsch S, Nuyttens Jet al. . ICRU Report 91. Prescribing, recording, and reporting of stereotactic treatments with small photon beams. J ICRU 2014;14:1–160. PubMed
IAEA . Comprehensive Audits of Radiotherapy Practices: A Tool for Quality Improvement. Quality Assurance Team for Radiation Oncology (QUATRO). ISBN 92–0–103707–4. 2007.
European Commission . Guideline on Clinical Audit for Medical Radiological Practices (Diagnostic Radiology, Nuclear Medicine, and Radiotherapy. Radiation Protection No. 159. ISBN 978-92-79-14281-9. 2009.
Casares-Magaz O, Marcu LG, Prezado Y, Koutsouveli E, Brambilla M. EFOMP Survey results on national radiotherapy dosimetry audits. Phys Med 2021;84:10–4. PubMed
Benedict SH, Yenice KM, Followill D, Hinson W, Kavanagh B, Keall Pet al. . Stereotactic body radiation therapy: the report of AAPM task group 101. Med Phys 2010;37(8):4078–101. PubMed
Akdag O, Borman PTS, Woodhead P, Uijtewaal P, Mandija S, Van Asselen Bet al. . First experimental exploration of real-time cardiorespiratory motion management for future stereotactic arrhythmia radioablation treatments on the MR-linac. Phys Med Biol 2022;67:065003. PubMed